Baker McKenzie advised Abbott Laboratories on the deal.Abbott Laboratories executed the acquisition of Cardiovascular Systems, Inc. in an all-cash transaction valued at approximately $890 million. Cardiovascular…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
